You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

kn026

Showing 1 - 6 of 6
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HER2-positive Locally Advanced Resectable Gastric Cancer Trial (KN026, KN046, XELOX)

Not yet recruiting
  • HER2-positive Locally Advanced Resectable Gastric Cancer
  • KN026
  • +2 more
  • (no location specified)
Sep 3, 2023

HER2-positive Colorectal Cancer, HER2-positive Biliary Tract Cancer Trial in Beijing (KN026, KN046, XELOX)

Not yet recruiting
  • HER2-positive Colorectal Cancer
  • HER2-positive Biliary Tract Cancer
  • KN026
  • +2 more
  • Beijing, State*, China
    Peking University cancer hospital & institution
Aug 2, 2023

First-line Treatment of HER2-positive Recurrent or Metastatic Breast Cancer Trial (KN026, HB1801, Pertuzumab)

Not yet recruiting
  • First-line Treatment of HER2-positive Recurrent or Metastatic Breast Cancer
  • KN026
  • +4 more
  • (no location specified)
Apr 20, 2023

Breast Cancer Trial in Shanghai (KN026)

Recruiting
  • Breast Cancer
  • KN026
  • Shanghai, Shanghai, China
    Fudan University Cancer Hospital
Jun 16, 2022

Breast Cancer, Gastric/Gastroesophageal Junction Cancer Trial in Greenville (KN026)

Active, not recruiting
  • Breast Cancer
  • Gastric/Gastroesophageal Junction Cancer
  • KN026
  • Greenville, South Carolina
    Greenville Health System Center Institute
Nov 16, 2021

Breast Cancer, Gastric Cancer Trial in Shanghai (KN026)

Active, not recruiting
  • Breast Cancer
  • Gastric Cancer
  • KN026
  • Shanghai, China
    Fudan University Shanghai Cancer Hospital
Nov 16, 2021